DrugPatentWatch Database Preview
Email this page to a colleague
« Back to Dashboard
Combretastatin is an investigational drug.
There have been 19 clinical trials for Combretastatin. The most recent clinical trial was a Phase 2 trial, which was initiated on March 1st 2015.
The most common disease conditions in clinical trials are Thyroid Neoplasms, Thyroid Carcinoma, Anaplastic, and Thyroid Diseases. The leading clinical trial sponsors are Mateon Therapeutics, National Cancer Institute (NCI), and Case Comprehensive Cancer Center.
There is one US patent protecting this investigational drug and thirteen international patents.
Recent Clinical Trials for Combretastatin
|FOCUS: PCC + Bevacizumab + CA4P Versus PCC + Bevacizumab + Placebo for Subjects With Platinum Resistant Ovarian Cancer||Mateon Therapeutics||Phase 2/Phase 3|
|Dose Escalation of OXi4503 as Single Agent and Combination With Cytarabine w/Subsequent Ph 2 Cohorts for AML and MDS||Mateon Therapeutics||Phase 1/Phase 2|
|Fosbretabulin or Placebo in Combination With Carboplatin/Paclitaxel in Anaplastic Thyroid Cancer||Mateon Therapeutics||Phase 3|
Top disease conditions for Combretastatin
Top clinical trial sponsors for Combretastatin
|Drugname||Patent Number||Patent Title||Patent Assignee||Estimated Expiration|
|Combretastatin||⤷ Try it Free||Method of diagnosing and treating cancer using B-catenin splice variants||The United States of America, as represented by the Secretary, Department of Health & Human Services (Washington, DC)||⤷ Try it Free|
|Combretastatin||⤷ Try it Free||Methods for the treatment of Kaposi's sarcoma or KSHV-induced lymphoma using immunomodulatory compounds, and uses of biomarkers||Celgene Corporation (Summit, NJ) The United States of America, as Represented by the Secretary, Department of Health and Human Services (Washington, DC)||⤷ Try it Free|
|Combretastatin||⤷ Try it Free||Use of inhibitors of Bruton'S tyrosine kinase (Btk)||Pharmacyclics LLC (Sunnyvale, CA)||⤷ Try it Free|
|>Drugname||>Patent Number||>Patent Title||>Patent Assignee||>Estimated Expiration|
|Drugname||Country||Document Number||Estimated Expiration||Related US Patent|
|Combretastatin||Argentina||AR075939||2029-03-25||⤷ Try it Free|
|Combretastatin||Australia||AU2010229994||2029-03-25||⤷ Try it Free|
|Combretastatin||Brazil||BRPI1006448||2029-03-25||⤷ Try it Free|
|>Drugname||>Country||>Document Number||>Estimated Expiration||>Related US Patent|